Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
Nobel Prize laureate Shinya Yamanaka, one of the world's most revered stem-cell researchers, takes part in "ice bucket challenge."
Dr. Warner Greene comments on advancements made in HIV research to Al Jazeera America, as the 20th Annual AIDS conference kicks off.
Researchers developing stem cell therapy to bolster immune system.
Truvada, the once-a-day pill to help keep people from contracting H.I.V., is on the cover of this week’s New York magazine, discussing how the pill is changing sex by drastically reducing gay men’s fear of infection.
Several concerns about a prescription drug used to prevent HIV infection in people at high risk are being put to rest by the results of new research.
There is more good news about HIV treatment pills used to prevent infection in people at high risk of getting the AIDS virus: Follow-up from a landmark study that proved the drug works now shows that it does not encourage risky sex and is effective even if people skip some doses.
Direct reprogramming of cardiac muscle cells into pacemaker cells gives pig hearts back their rhythm.
A new study by U.S. scientists revealed a way to alleviate the learning and memory deficits caused by a gene linked to Alzheimer's disease. By transplanting new cells into the brain, they saw improved brain activity, restoring cognition to normal levels in elderly mice.
With more than 5 million Americans living with Alzheimer's disease, the race is on to develop new treatments for the condition. Now, researchers from the Gladstone Institutes in San Francisco, CA, and the University of California-San Francisco reveal they have successfully reversed learning and memory deficits in mouse models of Alzheimer's through transplantation of healthy brain cells.
Compounds that boost the 'noise' in genetic activity of HIV can reactivate the latent virus. Such drugs could make it easier to stamp out quiescent HIV infections.